MétaCan
← all works

Triple-Negative Breast Cancer

2010· review· en· 4,170 citations· W2096027508 on OpenAlex· 10.1056/nejmra1001389

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.

Abstract

Triple-negative breast cancer, so called because it lacks expression of the estrogen receptor, progesterone receptor, and HER2, is often, but not always, a basal-like breast cancer. This review focuses on its origin, molecular and clinical characteristics, and treatment.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

The record

Venue
New England Journal of Medicine
Topic
Breast Cancer Treatment Studies
Field
Biochemistry, Genetics and Molecular Biology
Canadian institutions
McGill UniversityJewish General HospitalMcGill University Health Centre
Funders
Keywords
MedicineBreast cancerProgesterone receptorEstrogen receptorTriple-negative breast cancerCancerOncologyTriple negativeEstrogenInternal medicineCancer researchGynecology
Has abstract in OpenAlex
yes